AI
Saturday, May 31, 2025 12:08:09 AM
Merck makes the collaboration with Moderna look so real just like Merck signed the deal with Daiichi on three ADCs.See the comparison between Neoadjuvant PD1 inhibitor treatment and Moderna neoantigen therapy? Tell me which one has better results. Targeting for several neoantigens may have efficacy for a certain percentage of hot tumors. But it lacks of efficacy in treating cold tumors. If I am not mistaken, the trials between Merck and Moderna only target hot tumor.
Recent MRNA News
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
